Organon & Co. (OGN) Fundamentals

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada.
SHARE INFORMATION
Market Cap$ 6,548,993,715
Shares Outstanding254,329,853
Float225,484,032
Percent Float88.66%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.56
Latest Fiscal Revenue$ 6,304,000,000
Latest Fiscal EPS$ 5.32
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date2022-08-12
Dividend Rate$ 1.12
Dividend Yield4.35%
Payment CashCash
HOLDERS
Institutions2,012
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months22,124,822
Institutional Holdings Percent155.6%
Institutional Sold Previous 3 Months32,785,944
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months102,913
Insider Holdings Percent0.1
Insider Sold Previous 3 Months50,439
Insider Shares Owned144,178
TRADING INFO
52 Week High$ 39.48
52 Week Low$ 25.31
52 Week High Change$ -20.21
21 Day Moving Average$ 28.5524
21 Day Extended Moving Average$ 28.4547
50 Day Moving Average$ 30.1719
50 Day Extended Moving Average$ 30.0568
200 Day Moving Average$ 32.5757
200 Day Extended Moving Average$ 32.618
10 Day Average Volume1,952,909
20 Day Average Volume1,693,863
30 Day Average Volume1,595,869
50 Day Average Volume1,604,661
Alpha0.007975
Beta0.5450
Standard Deviation0.121392
R20.062023
7 Day Price Change$ -2.86
7 Day Percent Change-10.0%
21 Day Price Change$ -2.75
21 Day Percent Change-9.65%
30 Day Price Change$ -4.17
30 Day Percent Change-13.94%
Month to Date Price Change$ -2.78
Month to Date Percent Change-9.74%
Quarter to Date Price Change$ -7.70
Quarter to Date Percent Change-23.02%
180 Day Price Change$ -8.99
180 Day Percent Change-25.89%
200 Day Price Change$ -12.02
200 Day Percent Change-31.83%
Year to Date Price Change$ -3.95
Year to Date Percent Change-13.31%

Organon & Co. (OGN) Key Ratios

PROFITABILITY
EBIT Margin27.5%
EBITDA Margin30.9%
Pre-Tax Profit Margin0.0%
Profit Margin Count17.47%
Gross Margin62.9%
Profit Margin TOT17.47%
INCOME STATEMENTS
Revenue$ 6,355,000,000
Revenue Per Share$ 24.9872
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-1.00
Total Debt To Equity0.30
Int Coverage4.50
Current Ratio1.60
Leverage Ratio-7.90
Quick Ratio0.80
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio5.90
Enterprise Value$ 17,916,466,956
Price to Sales1.0305
Price to Free Cash-13.00
PE High Last 5 Years0.00
Price To Book1.80
Price To Cash Flow9.50
PE Low Last 5 Years0.00
Price to Tangible Book-1.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.10
Invoice Turnover2.70
Assets Turnover0.60
Return Assets10.93
Return on Equity-77.79
Return on Capital13.88

Organon & Co. (OGN) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorPricewaterhouseCoopers LLP
CEOKevin Ali
Emplyoees9300
Last AuditUQ
CIK0001821825
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address30 Hudson Street
Floor 33
Jersey City, NJ 7302
Websitehttps://www.organon.com
Facsimile-
Telephone+1 551 430-6900
Email-


Your Recent History
NYSE
OGN
Organon
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.